EUVIMED · CrossrefJournal
Canadian Liver Journal
ISSN 2561-4444 · University of Toronto Press Inc. (UTPress)
Latest articles
Virtual multidisciplinary clinic to manage alcohol use disorder in patients with alcohol-related liver disease: A clinic audit
Investigating the role of artificial intelligence in predicting risk factors after liver transplantation: A systematic review
Transarterial chemoembolization combined with sorafenib versus monotherapy for unresectable hepatocellular carcinoma: An umbrella review of meta-analyses
Myosteatosis as a prognostic biomarker for post-transplant survival and cardiometabolic outcomes: A retrospective study
The association between cirrhosis and outcomes among patients with lung cancer in Ontario between 2007 and 2017: A population-based study
Stigma related to hepatitis B virus: A barrier to global viral hepatitis elimination
Hepatitis B reactivation in HBsAg-/anti-HB-negative patients diagnosed with hematological malignancy: A case series
A feasibility study of a monitored home program to increase walking and decrease frailty in cirrhotic patients
Trends in chronic hepatitis C visits by providers in Quebec, Canada: A population-level cohort study
Steatotic liver disease in autoimmune liver disease: Prevalence and clinical impact in a Southeast Asian cohort
Cardiometabolic comorbidity and health outcomes of persons with metabolic dysfunction–associated steatotic liver disease (MASLD) in Ontario, Canada
Post-TIPS hepatic infarction: A dreaded prognosis-modifying complication
Evaluating the hepatitis C care cascade in Newfoundland and Labrador: Progress toward elimination
Quality of life and self-reported stigma following hepatitis B surface antigen loss: A multi-site study by the Canadian Hepatitis B Network
Canadian hepatology needs a strong, united Canada
Metabolic dysfunction–associated steatotic liver disease assessment and management: Clinical practice guidance from the Canadian Association for the Study of the Liver
Low muscle mass predicts liver-related outcomes in cirrhosis, independent of portal hypertension: A retrospective cohort study
Microbiome alternative treatments for hepatic encephalopathy: Reassessment of the potential use of lactose in lactase non-persistent cirrhosis patients
Gallbladder neoplasia is associated with a higher incidence of cholangiocarcinoma in patients with primary sclerosing cholangitis
Development and evaluation of a hybrid algorithm for identifying hospitalized patients with cirrhosis
Co-creating discovery in basic science: Challenges and opportunities in patient-partnered research for rare liver disease
Frequency of Helicobacter pylori screening in patients with end-stage liver disease prior to liver transplant
Portosystemic shunt (SPSS) embolization for refractory hepatic encephalopathy
Maralixibat for PFIC
Chronic ketamine use resulting in a reversible cholangiopathy: A case series from a single Canadian centre and review of the literature
Evaluation of a novel albumin platelet product (APP) fibrosis index and three non-invasive fibrosis indices in metabolic dysfunction–associated steatotic liver disease
Validation of FIB-4 for the diagnosis of liver cirrhosis in metabolic dysfunction-associated steatotic liver disease
The management of chronic hepatitis B: 2025 Guidelines update from the Canadian Association for the Study of the Liver and Association of Medical Microbiology and Infectious Disease Canada
Prevalence and predicting factors of caregiver burden in cirrhotic patients
Comparison of the magnetic resonance elastography and FIB-4 (MEFIB) Index and vibration-controlled transient elastography for significant metabolic dysfunction–associated steatotic liver disease fibrosis
EUVIMED